Study Designs Flashcards

case-control studies, cohort studies (34 cards)

1
Q

the common objective between cohort and case control studies

A

to investigate the association between exposures and disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

cohort characteristics

A

follows a group moving forward

start with groups by exposure status

key aspect is they are followed over time to see what their outcome is

confident in temporality sequence (exposure comes first)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are cohort studies good at measuring

A

incidence rates, and multiple outcomes from a single exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

when to use a cohort study

A

when an exposure is RARE (key), but disease rate is higher in those exposed

When there is good evidence of both the exposure and the disease of interest

When the cohort is stable and follow-up is feasible.

When you want to study multiple outcomes from a single exposure.

When ample resources and time are available.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

an epidemiological factor that cohort studies are good for

A

temporal
direction is always exposure-> outcome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

types of cohort studies

A

Prospective (concurrent):
Start now, follow into the
future

Retrospective (historical):
Use past records to follow up
to present

Ambidirectional:
Combination of both

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Comparison groups

A

Internal comparison: one cohort with subgroups by exposure status (e.g., smokers vs. non-smokers)

External comparison: two or more cohorts compared

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

General population (as a study group)

A
  • Whole population in a defined area
  • Representative sample
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

types of outcomes

A

discrete events (single i.e. mortality/first diagnosis, or multiple i.e. recurrent disease episodes)

continuous outcomes (repeated overtime i.e. blood pressure)

composite outcomes (combination of multiple endpoints into a single measure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Special groups
(as a study group)

A
  • Occupational/professional groups (e.g., Nurses’ Health Study)
  • Geographically defined groups (e.g., Framingham Heart Study)
  • Risk groups (e.g., San Francisco Men’s Health Study)
  • Exposure-defined groups — physical, chemical, biological
    agents or specific events (e.g., Japanese Atomic Bomb
    Survivors, 9/11 FDNY Workers Cohort
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

why does follow up matter

A

Ensures accurate outcome ascertainment

Minimizes loss to follow-up, which can bias results

Maintains study validity and statistical power

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

sources of outcome data

A

Active follow-up
* Mailed questionnaires
* Telephone calls or personal interviews
* Periodic medical examinations

Passive follow-up
* Linkage to medical records, hospital discharge databases, death registries
Cohort Studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how can we get bias?

A

loos to follow-up/attrition bias (a form of selection bias)

information bias (misclassification of exposure, misclassification of outcome)

confounding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

measures of association (cohort studies)

A

Mostly incidence rates:

Risk ratio (from cumulative incidence)

  • Rate ratio (from incidence rates)
  • Risk/rate differences
  • Hazard ratio (from time-to-event/survival) analysis)
  • Odds ratio (possible, but mainly for rare outcomes or logistic regression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

measures of frequency (cohort studies)

A

Cumulative incidence (risk)
* Incidence rate (person-time rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

case-control study features

A

Compare groups with a known outcome (cases) and without it (controls)

Look backward in time to determine prior exposure status

Measure and compare the odds of exposure between cases and controls

Exposure status is determined after the outcome has occurred → temporal sequence is less
certain

Can study multiple exposures for the same outcome

Efficient for rare outcomes or those with a long latency period

10
Q

case-control direction of time?

11
Q

when to use a case control study

A

When the outcome/disease is rare (low incidence in the population)

Long induction or latent period (e.g., cancer, cardiovascular disease)

When little is known about the disease and you need to explore potential risk factors (e.g., early
studies of AIDS).

When resources, time, or funding are limited (more efficient than a prospective cohort study)

When exposure data are expensive or difficult to obtain prospectively.

When rapid, early evidence is needed to guide public health action.

When studying multiple exposures (risk factors) for the same outcome.

11
Q

types of case control study

A

Population-based: Cases and controls are drawn from the same well-defined population (e.g.,
residents of a city, members of a health plan).

  • Hospital-based: Cases and controls selected from patients in the same hospital or clinic.
  • Nested case-control : Cases and controls identified from within an existing cohort study.
  • Case-cohort: Controls are a random sample of the original cohort, compared with all cases in
    the cohort.
  • Matched: Each case is paired with one or more controls with similar characteristics (e.g., age,
    sex, location) to reduce confounding.
  • Unmatched: Cases and controls selected independently without pairing on specific variables.
    Case-Control Studies
12
Q

what has to happen when determining the case group for case-control studies

A

Use precise, consistent diagnostic criteria to avoid misclassification.

13
Q

describe the control group in case control studies

A

Individuals from the same source population that produced the cases, but who do not have the
outcome of interest.

Purpose: To estimate the exposure distribution in the population from which the cases arose.

14
Q

types of controls

A

Population controls – e.g., community sampling, voter lists, registries; ensure same base population
as cases.

Hospital controls – patients admitted for conditions unrelated to the exposure of interest (e.g.,
orthopedic or surgical admissions in a smoking–MI study).

Friends/relatives – similar background and environment; relatives help control for genetic
confounding

15
Q

§ Counting, which is a key activity of epidemiologists, includes three steps

A

□ (1) developing a definition of disease
□ (2) instituting a mechanism for counting cases of disease within a specified population
□ (3) determining the size of that population.

16
Q

Majors forms of depression treatment

A

cognitive-behavioural therapy

Interpersonal psychotherapy

pharmacotherapy

17
Goals/Approach of CBT
teach the power of realistic thinking - find more effective/beneficial ways of thinking of themselves/the world/relationships and what is going on in the world activate behaviour -improve mood by engaging in behaviours that promote a sense of pleasure and mastery
18
Restructuring of thoughts in CBT
looking at evidence for their cognitions as well as the opposite looking explicitly at the thought and the situation
19
Interpersonal psychotherapy
Focus on identifying and amending lapses in interpersonal functioning that contribute to depression Focuses on interpersonal functioning/relationships, and uses the therapeutic relationship as a model to improve real world relationships
20
transference
IPT: Therapist becomes an important mirror for the client Client transfers their negative cognitive style to the therapist to see how it works
21
interpersonal functioning that someone could be struggling with
Interpersonal loss (grief) Interpersonal conflict Role transition Interpersonal deficit
22
most common form of treatment
pharmacotherapy
23
24
25
26